Connect With Us:
REPORT ID 6156

Global Neuroendocrine Tumor Drug Market ResearchReport 2019

Publish Date
2019
Pages
110
Format
Electronic (PDF)

Full report description 
In this report, the global Neuroendocrine Tumor Drug market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neuroendocrine Tumor Drug in these regions, from   2019 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Neuroendocrine Tumor Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Eisai
    Exelixis, Inc.
    Foresee Pharmaceuticals, LLC
    Hutchison MediPharma Limited
    Intezyne, Inc
    INVENT Pharmaceuticals, Inc.
    Ipsen S.A.
    Jiangsu Hengrui Medicine Co., Ltd.
    Karyopharm Therapeutics, Inc.
    Lexicon Pharmaceuticals, Inc.
    Midatech Pharma Plc .
    Millennium Pharmaceuticals, Inc.
    MolMed S.p.A.
    Northwest Biotherapeutics, Inc.
    Novartis AG
    OctreoPharm Sciences GmbH
    OXiGENE, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    mTOR protein inhibitors
    Tyrosine kinase 3 inhibitors
    Somatostatin receptor antagonists
    Growth hormone releasing factor antagonists
    Somatostatin receptor agonists
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of contents 
Table of Contents

Global Neuroendocrine Tumor Drug Market Research  Report 2019
1 Neuroendocrine Tumor Drug Market Overview
    1.1 Product Overview and Scope of Neuroendocrine Tumor Drug
    1.2 Neuroendocrine Tumor Drug Segment by Type (Product Category)
        1.2.1 Global Neuroendocrine Tumor Drug Production and CAGR (%) Comparison by Type (Product Category)( 2014-2024)
        1.2.2 Global Neuroendocrine Tumor Drug Production Market Share by Type (Product Category)  in 2018
        1.2.3 mTOR protein inhibitors
        1.2.4 Tyrosine kinase 3 inhibitors
        1.2.5 Somatostatin receptor antagonists
        1.2.6 Growth hormone releasing factor antagonists
        1.2.7 Somatostatin receptor agonists
        1.2.8 Others
    1.3 Global Neuroendocrine Tumor Drug Segment by Application
        1.3.1 Neuroendocrine Tumor Drug Consumption (Sales) Comparison by Application ( 2014-2024)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Neuroendocrine Tumor Drug Market by Region ( 2014-2024)
        1.4.1 Global Neuroendocrine Tumor Drug Market Size (Value) and CAGR (%) Comparison by Region ( 2014-2024)
        1.4.2 North America Status and Prospect ( 2014-2024)
        1.4.3 Europe Status and Prospect ( 2014-2024)
        1.4.4 China Status and Prospect ( 2014-2024)
        1.4.5 Japan Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.7 India Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value) of Neuroendocrine Tumor Drug ( 2014-2024)
        1.5.1 Global Neuroendocrine Tumor Drug Revenue Status and Outlook ( 2014-2024)
        1.5.2 Global Neuroendocrine Tumor Drug Capacity, Production Status and Outlook ( 2014-2024)

2 Global Neuroendocrine Tumor Drug Market Competition by Manufacturers
    2.1 Global Neuroendocrine Tumor Drug Capacity, Production and Share by Manufacturers ( 2014-2019)
        2.1.1 Global Neuroendocrine Tumor Drug Capacity and Share by Manufacturers ( 2014-2019)
        2.1.2 Global Neuroendocrine Tumor Drug Production and Share by Manufacturers ( 2014-2019)
    2.2 Global Neuroendocrine Tumor Drug Revenue and Share by Manufacturers ( 2014-2019)
    2.3 Global Neuroendocrine Tumor Drug Average Price by Manufacturers ( 2014-2019)
    2.4 Manufacturers Neuroendocrine Tumor Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Neuroendocrine Tumor Drug Market Competitive Situation and Trends
        2.5.1 Neuroendocrine Tumor Drug Market Concentration Rate
        2.5.2 Neuroendocrine Tumor Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue (Value) by Region ( 2014-2019)
    3.1 Global Neuroendocrine Tumor Drug Capacity and Market Share by Region ( 2014-2019)
    3.2 Global Neuroendocrine Tumor Drug Production and Market Share by Region ( 2014-2019)
    3.3 Global Neuroendocrine Tumor Drug Revenue (Value) and Market Share by Region ( 2014-2019)
    3.4 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.5 North America Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.6 Europe Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.7 China Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.8 Japan Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.9 Southeast Asia Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.10 India Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)

4 Global Neuroendocrine Tumor Drug Supply (Production), Consumption, Export, Import by Region ( 2014-2019)
    4.1 Global Neuroendocrine Tumor Drug Consumption by Region ( 2014-2019)
    4.2 North America Neuroendocrine Tumor Drug Production, Consumption, Export, Import ( 2014-2019)
    4.3 Europe Neuroendocrine Tumor Drug Production, Consumption, Export, Import ( 2014-2019)
    4.4 China Neuroendocrine Tumor Drug Production, Consumption, Export, Import ( 2014-2019)
    4.5 Japan Neuroendocrine Tumor Drug Production, Consumption, Export, Import ( 2014-2019)
    4.6 Southeast Asia Neuroendocrine Tumor Drug Production, Consumption, Export, Import ( 2014-2019)
    4.7 India Neuroendocrine Tumor Drug Production, Consumption, Export, Import ( 2014-2019)

5 Global Neuroendocrine Tumor Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Neuroendocrine Tumor Drug Production and Market Share by Type ( 2014-2019)
    5.2 Global Neuroendocrine Tumor Drug Revenue and Market Share by Type ( 2014-2019)
    5.3 Global Neuroendocrine Tumor Drug Price by Type ( 2014-2019)
    5.4 Global Neuroendocrine Tumor Drug Production Growth by Type ( 2014-2019)

6 Global Neuroendocrine Tumor Drug Market Analysis by Application
    6.1 Global Neuroendocrine Tumor Drug Consumption and Market Share by Application ( 2014-2019)
    6.2 Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application ( 2014-2019)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Neuroendocrine Tumor Drug Manufacturers Profiles/Analysis
    7.1 Eisai
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Eisai Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.1.4 Main Business/Business Overview
    7.2 Exelixis, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.2.4 Main Business/Business Overview
    7.3 Foresee Pharmaceuticals, LLC
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.3.4 Main Business/Business Overview
    7.4 Hutchison MediPharma Limited
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.4.4 Main Business/Business Overview
    7.5 Intezyne, Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.5.4 Main Business/Business Overview
    7.6 INVENT Pharmaceuticals, Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.6.4 Main Business/Business Overview
    7.7 Ipsen S.A.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.7.4 Main Business/Business Overview
    7.8 Jiangsu Hengrui Medicine Co., Ltd.
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.8.4 Main Business/Business Overview
    7.9 Karyopharm Therapeutics, Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.9.4 Main Business/Business Overview
    7.10 Lexicon Pharmaceuticals, Inc.
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.10.4 Main Business/Business Overview
    7.11 Midatech Pharma Plc .
    7.12 Millennium Pharmaceuticals, Inc.
    7.13 MolMed S.p.A.
    7.14 Northwest Biotherapeutics, Inc.
    7.15 Novartis AG
    7.16 OctreoPharm Sciences GmbH
    7.17 OXiGENE, Inc.

8 Neuroendocrine Tumor Drug Manufacturing Cost Analysis
    8.1 Neuroendocrine Tumor Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Neuroendocrine Tumor Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Neuroendocrine Tumor Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Neuroendocrine Tumor Drug Market Forecast ( 2019-2025)
    12.1 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue Forecast ( 2019-2025)
        12.1.1 Global Neuroendocrine Tumor Drug Capacity, Production and Growth Rate Forecast ( 2019-2025)
        12.1.2 Global Neuroendocrine Tumor Drug Revenue and Growth Rate Forecast ( 2019-2025)
        12.1.3 Global Neuroendocrine Tumor Drug Price and Trend Forecast ( 2019-2025)
    12.2 Global Neuroendocrine Tumor Drug Production, Consumption , Import and Export Forecast by Region ( 2019-2025)
        12.2.1 North America Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.2 Europe Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.3 China Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.4 Japan Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.5 Southeast Asia Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.6 India Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
    12.3 Global Neuroendocrine Tumor Drug Production, Revenue and Price Forecast by Type ( 2019-2025)
    12.4 Global Neuroendocrine Tumor Drug Consumption Forecast by Application ( 2019-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer